Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe IVD In Cardiology And Neurology Market, by Product Type
1.4.2 Europe IVD In Cardiology And Neurology Market, by End Use
1.4.3 Europe IVD In Cardiology And Neurology Market, by Technology
1.4.4 Europe IVD In Cardiology And Neurology Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe IVD In Cardiology And Neurology Market by Product Type
4.1 Europe Reagents & Consumables Market by Country
4.2 Europe Instruments Market by Country
4.3 Europe Software & Services Market by Country
Chapter 5. Europe IVD In Cardiology And Neurology Market by End-use
5.1 Europe Hospitals Market by Country
5.2 Europe Clinical Laboratories Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe IVD In Cardiology And Neurology Market by Technology
6.1 Europe Immunoassays Market by Country
6.2 Europe Molecular Diagnostics Market by Country
6.3 Europe Hematology Market by Country
6.4 Europe Others Market by Country
Chapter 7. Europe IVD In Cardiology And Neurology Market by Country
7.1 Germany IVD In Cardiology And Neurology Market
7.1.1 Germany IVD In Cardiology And Neurology Market by Product Type
7.1.2 Germany IVD In Cardiology And Neurology Market by End-use
7.1.3 Germany IVD In Cardiology And Neurology Market by Technology
7.2 UK IVD In Cardiology And Neurology Market
7.2.1 UK IVD In Cardiology And Neurology Market by Product Type
7.2.2 UK IVD In Cardiology And Neurology Market by End-use
7.2.3 UK IVD In Cardiology And Neurology Market by Technology
7.3 France IVD In Cardiology And Neurology Market
7.3.1 France IVD In Cardiology And Neurology Market by Product Type
7.3.2 France IVD In Cardiology And Neurology Market by End-use
7.3.3 France IVD In Cardiology And Neurology Market by Technology
7.4 Russia IVD In Cardiology And Neurology Market
7.4.1 Russia IVD In Cardiology And Neurology Market by Product Type
7.4.2 Russia IVD In Cardiology And Neurology Market by End-use
7.4.3 Russia IVD In Cardiology And Neurology Market by Technology
7.5 Spain IVD In Cardiology And Neurology Market
7.5.1 Spain IVD In Cardiology And Neurology Market by Product Type
7.5.2 Spain IVD In Cardiology And Neurology Market by End-use
7.5.3 Spain IVD In Cardiology And Neurology Market by Technology
7.6 Italy IVD In Cardiology And Neurology Market
7.6.1 Italy IVD In Cardiology And Neurology Market by Product Type
7.6.2 Italy IVD In Cardiology And Neurology Market by End-use
7.6.3 Italy IVD In Cardiology And Neurology Market by Technology
7.7 Rest of Europe IVD In Cardiology And Neurology Market
7.7.1 Rest of Europe IVD In Cardiology And Neurology Market by Product Type
7.7.2 Rest of Europe IVD In Cardiology And Neurology Market by End-use
7.7.3 Rest of Europe IVD In Cardiology And Neurology Market by Technology
Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 F. Hoffmann-La Roche Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Sysmex Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Siemens Healthineers AG (Siemens AG)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 Quest Diagnostics Incorporated
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Acquisition and Mergers:
8.5.5 SWOT Analysis
8.6 Abbott Laboratories
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Bio-Rad laboratories, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Danaher Corporation (Beckman Coulter)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Becton, Dickinson, and Company
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Natera Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis
Unique Offerings 